Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023
   Working Capital/Sales(x) 0.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 0.79 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹110.2 Cr 1% -1.5% -12.5% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹11,226.3 Cr -0.8% 13.8% 47.8% Stock Analytics
KIRI INDUSTRIES ₹3,166.2 Cr -0.4% -9% 46.9% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,839.7 Cr -4.1% -7.9% -16.3% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,110.6 Cr -0.4% -10.3% 42.3% Stock Analytics
BODAL CHEMICALS ₹850.6 Cr 3.3% -10.9% -13% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

1%

-1.5%

-12.5%

SENSEX

1.8%

-0.2%

2%


You may also like the below Video Courses